Shinji Mii

13PUBLICATIONS
83CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsNeurosciences not elsewhere classifiedPacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2026
Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.

|Dec 16, 2025
Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.

Xingxing Wang, Keiko Shinjo, Kohei Kumegawa

|Oct 21, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.

Nobutoshi Esaki, Tomoka Sakoda, Ryota Ando

|Jun 30, 2025
Rectal Neuroendocrine Tumor With Non-Atypical Mucous Cell Glands: A Case Report.

Akira Ishikawa, Hidenori Tanaka, Ken Yamashita

|Apr 29, 2025
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.

Ling Cai, Fangjiang Wu, Qinbo Zhou

|Aug 13, 2024
Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis.

Toshikazu Ishihara, Katsuhiro Kato, Kotaro Matsumoto

Pageof 3

Frequent Collaborators

8 joint publications

Atsushi Enomoto

5 joint publications

Masahide Takahashi

4 joint publications

Yukihiro Shiraki

3 joint publications

Tetsuro Taki